Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jessica Boulos"'
Autor:
Timothy Samec, Kharimat Lora Alatise, Jessica Boulos, Serena Gilmore, Anthony Hazelton, Carleigh Coffin, Angela Alexander-Bryant
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 30, Iss , Pp 95-111 (2022)
Ovarian cancer has shown little improvement in survival among advanced-stage patients over the past decade. Current treatment strategies have been largely unsuccessful in treating advanced disease, with many patients experiencing systemic toxicity an
Externí odkaz:
https://doaj.org/article/6a4af8abcae046f6ba6452cffbc2e0ab
Publikováno v:
Materials Today Bio, Vol 14, Iss , Pp 100248- (2022)
Current delivery strategies for cancer therapeutics commonly cause significant systemic side effects due to required high doses of therapeutic, inefficient cellular uptake of drug, and poor cell selectivity. Peptide-based delivery systems have shown
Externí odkaz:
https://doaj.org/article/6a31904a838842e6914e9ebd2677ce18
Publikováno v:
Materials today. Bio. 14
Current delivery strategies for cancer therapeutics commonly cause significant systemic side effects due to required high doses of therapeutic, inefficient cellular uptake of drug, and poor cell selectivity. Peptide-based delivery systems have shown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6abaa579a7c3a35dd291cc77313d5b1
https://pubmed.ncbi.nlm.nih.gov/35434595
https://pubmed.ncbi.nlm.nih.gov/35434595
Publikováno v:
Cancer Research. 81:1310-1310
Glioblastoma Multiforme (GBM), a grade VI glioma, is an aggressive malignant tumorwith a poor prognosis. With an incidence rate of 3.19 per 100,000, GBM has a median survivalrate of 12-15 months and a five-year survival rate of less than 5%. Typical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40906c8e7e11d65503ba46a54c108fa0
https://doi.org/10.1158/1538-7445.am2021-1310
https://doi.org/10.1158/1538-7445.am2021-1310
Publikováno v:
Cancer Research. 81:304-304
Background Ovarian cancer (OC) is among the most commonly diagnosed cancers and combined with the low responses to therapeutics, it has the highest mortality among gynecological cancers. When diagnosed at stage III and stage IV, survival rates remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f1dfc4222b2f338793e9c62cbaa8259
https://doi.org/10.1158/1538-7445.am2021-304
https://doi.org/10.1158/1538-7445.am2021-304
Publikováno v:
Cancer Research. 80:2868-2868
Introduction: Ovarian cancer recurrence and survival rates have remained stagnant over time with current therapeutics displaying low efficacy and often rendered ineffective by degradation. This work presents novel fusogenic peptides that will electro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6dac5c0f34c82e10ea903c7946e13302
https://doi.org/10.1158/1538-7445.am2020-2868
https://doi.org/10.1158/1538-7445.am2020-2868